Nephrotic syndrome is characterized by massive proteinuria, hypoalbuminemia, edema, hyperlipidemia, hypertension and rarely hematuria. It is an important chronic disease in children of age 2 to 7 year old. Management of nephrotic syndrome includes prednisolone 2mg/kg/day (maximum 60 mg) in single or divided doses for 6 weeks, followed by 1.5 mg/kg (maximum 40 mg) as a single morning dose on alternate days for next 6 weeks. The present study is designed to evaluate the efficacy and safety of zinc as an add on therapy to prednisolone for producing early remission of pediatric nephrotic syndrome. 62 children fulfilling the inclusion criteria will be included in the study. The total duration of the study will be 12 months., To the check the efficacy of zinc which includes urinary assessment, spot urine protein creatinine ratio, BP, 24hr urine output, fluid intake, Abdominal girth will be assessed daily, however serum electrolyte, serum protein, lipid profile, serum creatinine, serum urea will be estimated at baseline and on the day of remission. Data will be entered into Microsoft excel sheet, an analytical software will be used for doing statistical analysis. Mean ± S.D will be calculated for quantitative data. Percentage and proportion will be calculated for qualitative data. Wills test will be used to check the normality of the data. Student t-test / Mann Whitney test will be used to find out the mean difference between two groups. Chi square test will be used to find out the association between categorical data using SPSS (statistical programme for social science) version-20 software. A P- value <0.05 will be considered as statistically significant.